https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27917 Wed 24 May 2023 11:32:49 AEST ]]> Optimising implementation of telehealth in oncology: A systematic review examining barriers and enablers using the RE-AIM planning and evaluation framework https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53335 Wed 22 Nov 2023 10:13:06 AEDT ]]> Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36471 Wed 17 Nov 2021 16:29:19 AEDT ]]> Supportive care needs of hematological cancer survivors: a critical review of the literature https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:14135 Wed 11 Apr 2018 15:35:24 AEST ]]> Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: report of 5 cases and literature review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29675 Wed 02 Mar 2022 14:26:49 AEDT ]]> Metastatic melanoma treatment: combining old and new therapies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29594 Thu 03 Feb 2022 12:21:03 AEDT ]]> The psychosocial outcomes of individuals with hematological cancers: are we doing enough high quality research, and what is it telling us? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25451 Fri 10 Mar 2023 18:02:18 AEDT ]]>